drugset / Trial / NCT00604409

Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer

NCT00604409 ↗

Phase 1 Completed 34 enrolled Fox Chase Cancer Center Sirtex Medical · collab
NaSingle-groupOpen-labelTreatment

Summary

This trial is testing the safety of combining the oral chemotherapy drug capecitabine with radio-labeled microspheres injected directly into the liver.

Timeline

Start
2006-04
Primary completion
2014-06
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule — Oral

Indications